These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 16096402)

  • 21. Atypical Spitz Tumors: A Diagnostic Challenge.
    Harms KL; Lowe L; Fullen DR; Harms PW
    Arch Pathol Lab Med; 2015 Oct; 139(10):1263-70. PubMed ID: 26414472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
    Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
    Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are all melanomas the same? Spitzoid melanoma is a distinct subtype of melanoma.
    Lee DA; Cohen JA; Twaddell WS; Palacios G; Gill M; Levit E; Halperin AJ; Mones J; Busam KJ; Silvers DN; Celebi JT
    Cancer; 2006 Feb; 106(4):907-13. PubMed ID: 16421887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics associated with Spitz nevi and Spitzoid malignant melanomas: the Yale University Spitzoid Neoplasm Repository experience, 1991 to 2008.
    Lott JP; Wititsuwannakul J; Lee JJ; Ariyan S; Narayan D; Kluger HH; Lazova R
    J Am Acad Dermatol; 2014 Dec; 71(6):1077-82. PubMed ID: 25308882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours.
    van Dijk MC; Rombout PD; Mooi WJ; van de Molengraft FJ; van Krieken JH; Ruiter DJ; Ligtenberg MJ
    J Pathol; 2002 Jun; 197(2):170-8. PubMed ID: 12015740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric "STUMP" lesions: evaluation and management of difficult atypical Spitzoid lesions in children.
    Tom WL; Hsu JW; Eichenfield LF; Friedlander SF
    J Am Acad Dermatol; 2011 Mar; 64(3):559-72. PubMed ID: 21255872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features.
    Raghavan SS; Wang JY; Kwok S; Rieger KE; Novoa RA; Brown RA
    J Cutan Pathol; 2020 Dec; 47(12):1123-1131. PubMed ID: 32700786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
    Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
    Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report.
    Vachtenheim J; Kodet R; Fischer O; Kolek V; Strizova Z; Ozaniak A; Simonek J; Stolz A; Pozniak J; Kolarik J; Svorcova M; Vachtenheim J; Lischke R
    Diagn Pathol; 2020 Oct; 15(1):132. PubMed ID: 33100226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benign and Intermediate-grade Melanocytic Tumors With BRAF Mutations and Spitzoid Morphology: A Subset of Melanocytic Neoplasms Distinct From Melanoma.
    Zhao J; Benton S; Zhang B; Olivares S; Asadbeigi S; Busam K; Gerami P
    Am J Surg Pathol; 2022 Apr; 46(4):476-485. PubMed ID: 34753863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma.
    Requena C; Rubio L; Traves V; Sanmartín O; Nagore E; Llombart B; Serra C; Fernández-Serra A; Botella R; Guillén C
    Histopathology; 2012 Nov; 61(5):899-909. PubMed ID: 22882594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Copy number variations and clinical outcome in atypical spitz tumors.
    Raskin L; Ludgate M; Iyer RK; Ackley TE; Bradford CR; Johnson TM; Fullen DR
    Am J Surg Pathol; 2011 Feb; 35(2):243-52. PubMed ID: 21263245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spitz Nevus and Other Spitzoid Tumors in Children -Part 1: Clinical, Histopathologic, and Immunohistochemical Features.
    Sainz-Gaspar L; Sánchez-Bernal J; Noguera-Morel L; Hernández-Martín A; Colmenero I; Torrelo A
    Actas Dermosifiliogr (Engl Ed); 2020 Jan; 111(1):7-19. PubMed ID: 31787210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ciliation Index Is a Useful Diagnostic Tool in Challenging Spitzoid Melanocytic Neoplasms.
    Lang UE; Torres R; Cheung C; Vladar EK; McCalmont TH; Kim J; Judson-Torres RL
    J Invest Dermatol; 2020 Jul; 140(7):1401-1409.e2. PubMed ID: 31978411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HRAS-mutated Spitz tumors: A subtype of Spitz tumors with distinct features.
    van Engen-van Grunsven AC; van Dijk MC; Ruiter DJ; Klaasen A; Mooi WJ; Blokx WA
    Am J Surg Pathol; 2010 Oct; 34(10):1436-41. PubMed ID: 20871217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-reactivity of NRASQ61R antibody in a subset of Spitz nevi with 11p gain: a potential confounding factor in the era of pathway-based diagnostic approach.
    Parra O; Lefferts JA; Tafe LJ; Gru AA; Linos K
    Hum Pathol; 2021 Jun; 112():35-47. PubMed ID: 33636207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of p15 in a spectrum of spitzoid melanocytic neoplasms.
    Ma SA; O'Day CP; Dentchev T; Takeshita J; Ridky TW; Seykora JT; Chu EY
    J Cutan Pathol; 2019 May; 46(5):310-316. PubMed ID: 30666677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restrospective reappraisal of the prognostic classification of spitzoid melanocytic neoplasms after BRAF and NRAS mutation characterisation: a single institution experience.
    Moysset I; Castrejon N; Garcia-Herrera A; Castillo P; Marginet M; Teixido C; Podlipnik S; Albero-Gonzalez R; Montironi C; Navarro J; Rovira C; Puig S; Carrera C; Alos L
    Histopathology; 2024 Jun; 84(7):1154-1166. PubMed ID: 38409889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spitzoid tumors in children and adults: a comparative clinical, pathological, and cytogenetic analysis.
    Dika E; Fanti PA; Fiorentino M; Capizzi E; Neri I; Piraccini BM; Ravaioli GM; Misciali C; Passarini B; Patrizi A
    Melanoma Res; 2015 Aug; 25(4):295-301. PubMed ID: 25933206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors.
    Redon S; Guibourg B; Talagas M; Marcorelles P; Uguen A
    Appl Immunohistochem Mol Morphol; 2018; 26(10):714-720. PubMed ID: 28362709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.